$SDGR
Schrodinger, Inc.

2022 Q3 Form 10-Q Financial Statement

#000149097822000012 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q4
Revenue $36.98M $46.17M
YoY Change 23.89% 39.78%
Cost Of Revenue $19.78M $19.81M
YoY Change 5.57% 41.09%
Gross Profit $17.20M $26.36M
YoY Change 54.75% 38.82%
Gross Profit Margin 46.51% 57.1%
Selling, General & Admin $30.48M $23.73M
YoY Change 35.04% 29.96%
% of Gross Profit 177.19% 90.02%
Research & Development $32.89M $25.15M
YoY Change 41.63% 45.18%
% of Gross Profit 191.18% 95.39%
Depreciation & Amortization $1.107M $652.0K
YoY Change 90.53% -35.45%
% of Gross Profit 6.44% 2.47%
Operating Expenses $63.36M $48.88M
YoY Change 38.38% 37.37%
Operating Profit -$46.16M -$22.52M
YoY Change 33.13% 35.71%
Interest Expense $6.501M -$7.926M
YoY Change -2006.45% -251.84%
% of Operating Profit
Other Income/Expense, Net $6.501M
YoY Change -2006.45%
Pretax Income -$39.66M -$30.44M
YoY Change 13.27% 167.97%
Income Tax $194.0K $274.0K
% Of Pretax Income
Net Earnings -$39.85M -$30.71M
YoY Change 13.84% 175.7%
Net Earnings / Revenue -107.77% -66.52%
Basic Earnings Per Share -$0.56
Diluted Earnings Per Share -$0.56 -$433.0K
COMMON SHARES
Basic Shares Outstanding 71.21M shares
Diluted Shares Outstanding 71.21M shares

Balance Sheet

Concept 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $473.6M $576.5M
YoY Change -20.7% -10.3%
Cash & Equivalents $102.8M $120.3M
Short-Term Investments $370.7M $456.2M
Other Short-Term Assets $14.91M $8.030M
YoY Change 75.19% 63.88%
Inventory
Prepaid Expenses $9.104M $5.030M
Receivables $23.58M $31.74M
Other Receivables $1.098M $536.0K
Total Short-Term Assets $524.2M $625.1M
YoY Change -15.73% -8.48%
LONG-TERM ASSETS
Property, Plant & Equipment $13.76M $10.03M
YoY Change -83.92% 95.04%
Goodwill $4.791M $0.00
YoY Change
Intangibles $720.0K $0.00
YoY Change
Long-Term Investments $27.18M $43.17M
YoY Change -46.8% -5.47%
Other Assets $2.879M $2.851M
YoY Change -27.52% 21.22%
Total Long-Term Assets $137.8M $131.4M
YoY Change -2.0% 107.67%
TOTAL ASSETS
Total Short-Term Assets $524.2M $625.1M
Total Long-Term Assets $137.8M $131.4M
Total Assets $662.0M $756.5M
YoY Change -13.2% 1.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.92M $8.079M
YoY Change 32.69% -3.8%
Accrued Expenses $33.98M $27.76M
YoY Change 63.27% 43.11%
Deferred Revenue $55.37M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $88.82M $91.21M
YoY Change 21.81% 24.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $900.0K $300.0K
YoY Change -99.18% -54.13%
Total Long-Term Liabilities $900.0K $300.0K
YoY Change -99.18% -54.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $88.82M $91.21M
Total Long-Term Liabilities $900.0K $300.0K
Total Liabilities $198.9M $199.4M
YoY Change 8.78% 63.12%
SHAREHOLDERS EQUITY
Retained Earnings -$351.9M -$230.0M
YoY Change 76.64% 77.49%
Common Stock $818.0M $787.0M
YoY Change 5.02% 4.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $463.1M $557.1M
YoY Change
Total Liabilities & Shareholders Equity $662.0M $756.5M
YoY Change -13.2% 1.37%

Cashflow Statement

Concept 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income -$39.85M -$30.71M
YoY Change 13.84% 175.7%
Depreciation, Depletion And Amortization $1.107M $652.0K
YoY Change 90.53% -35.45%
Cash From Operating Activities -$30.36M -$19.74M
YoY Change 185.42% -145.25%
INVESTING ACTIVITIES
Capital Expenditures -$2.998M -$957.0K
YoY Change 7.73% 7.53%
Acquisitions
YoY Change
Other Investing Activities $10.84M -$21.13M
YoY Change -80.35% -59.63%
Cash From Investing Activities $7.840M -$22.09M
YoY Change -85.03% -58.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 324.0K 1.217M
YoY Change -77.53% -14.3%
NET CHANGE
Cash From Operating Activities -30.36M -19.74M
Cash From Investing Activities 7.840M -22.09M
Cash From Financing Activities 324.0K 1.217M
Net Change In Cash -22.20M -40.61M
YoY Change -151.41% 395.27%
FREE CASH FLOW
Cash From Operating Activities -$30.36M -$19.74M
Capital Expenditures -$2.998M -$957.0K
Free Cash Flow -$27.37M -$18.78M
YoY Change 248.38% -142.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001490978
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39206
dei Entity Registrant Name
EntityRegistrantName
Schrodinger, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4284541
dei Entity Address Address Line1
EntityAddressAddressLine1
1540 Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
24th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
295-5800
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
SDGR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102817000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120267000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
5803000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3000000 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
370739000 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
456212000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
124000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
108000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23583000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31744000 usd
CY2022Q3 sdgr Allowance For Unbilled Receivables Current
AllowanceForUnbilledReceivablesCurrent
40000 usd
CY2021Q4 sdgr Allowance For Unbilled Receivables Current
AllowanceForUnbilledReceivablesCurrent
30000 usd
CY2022Q3 sdgr Unbilled And Other Receivables Current
UnbilledAndOtherReceivablesCurrent
12155000 usd
CY2021Q4 sdgr Unbilled And Other Receivables Current
UnbilledAndOtherReceivablesCurrent
8807000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9104000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5030000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
524201000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
625060000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13755000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10025000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
27177000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
43167000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
4791000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
0 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
720000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
88462000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
75384000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2879000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2851000 usd
CY2022Q3 us-gaap Assets
Assets
661985000 usd
CY2021Q4 us-gaap Assets
Assets
756487000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10918000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8079000 usd
CY2022Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
18904000 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
18405000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43920000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
55368000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8683000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2042000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6396000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7317000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
88821000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91211000 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
21977000 usd
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
30064000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87165000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77827000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
900000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
300000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
198863000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
199402000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
818015000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
786964000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351931000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229952000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3686000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-651000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
463110000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
557071000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
12000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
14000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
463122000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
557085000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
661985000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
756487000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36980000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29850000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124112000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91761000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
19779000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
18735000 usd
us-gaap Cost Of Revenue
CostOfRevenue
61794000 usd
us-gaap Cost Of Revenue
CostOfRevenue
52502000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
17201000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
11115000 usd
us-gaap Gross Profit
GrossProfit
62318000 usd
us-gaap Gross Profit
GrossProfit
39259000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32885000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23219000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91830000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65759000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7161000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5556000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21260000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16175000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23318000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17014000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
67507000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46253000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
63364000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
45789000 usd
us-gaap Operating Expenses
OperatingExpenses
180597000 usd
us-gaap Operating Expenses
OperatingExpenses
128187000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-46163000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-34674000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-118279000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-88928000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11825000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1781000 usd
CY2022Q3 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
5273000 usd
CY2021Q3 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-627000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-16591000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
19279000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1231000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
286000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1263000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1063000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6501000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-341000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3503000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18561000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39662000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35015000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-121782000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70367000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
199000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
137000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-39856000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-35011000 usd
us-gaap Profit Loss
ProfitLoss
-121981000 usd
us-gaap Profit Loss
ProfitLoss
-70504000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-824000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-39853000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-35007000 usd
us-gaap Net Income Loss
NetIncomeLoss
-121979000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69680000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.99
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71207992 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71207992 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70784184 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70784184 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71140682 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71140682 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70481901 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70481901 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-39853000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-35007000 usd
us-gaap Net Income Loss
NetIncomeLoss
-121979000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69680000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-283000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-32000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3035000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-273000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40136000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35039000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-125014000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-69953000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
557085000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2006000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
908000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9134000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-34451000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
530670000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-746000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
396000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10427000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-47674000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
493073000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-283000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
324000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9864000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-39856000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
463122000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
624019000 usd
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-240000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3656000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4366000 usd
CY2021Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
498000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-523000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
631776000 usd
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1612000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7016000 usd
CY2021Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
338000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-34970000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
605771000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-32000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1442000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7652000 usd
CY2021Q3 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-35011000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
579822000 usd
us-gaap Profit Loss
ProfitLoss
-121981000 usd
us-gaap Profit Loss
ProfitLoss
-70504000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11825000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1781000 usd
sdgr Noncash Revenue From Equity Investments
NoncashRevenueFromEquityInvestments
0 usd
sdgr Noncash Revenue From Equity Investments
NoncashRevenueFromEquityInvestments
59000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-16591000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
19279000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3202000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2195000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
29425000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
19034000 usd
sdgr Research And Development Noncash Expense
ResearchAndDevelopmentNoncashExpense
0 usd
sdgr Research And Development Noncash Expense
ResearchAndDevelopmentNoncashExpense
811000 usd
sdgr Investment Amortization Noncash Expense
InvestmentAmortizationNoncashExpense
-2102000 usd
sdgr Investment Amortization Noncash Expense
InvestmentAmortizationNoncashExpense
-4736000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-14000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-140000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8673000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20071000 usd
sdgr Increase Decrease In Unbilled And Other Receivables
IncreaseDecreaseInUnbilledAndOtherReceivables
3272000 usd
sdgr Increase Decrease In Unbilled And Other Receivables
IncreaseDecreaseInUnbilledAndOtherReceivables
1358000 usd
sdgr Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets
IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssets
-4812000 usd
sdgr Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets
IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssets
-4724000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6837000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2720000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2597000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-229000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
499000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2010000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-19535000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-10190000 usd
sdgr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
920000 usd
sdgr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-3705000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-126000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1611000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-94741000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50931000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6668000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6210000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
600000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3700000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
11825000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
375000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
15735000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6427000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
203375000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
340509000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
283711000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
339588000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
78466000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5279000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1628000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6710000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
25000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1628000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6735000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14647000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-38917000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123267000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202796000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108620000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163879000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
462000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
236000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
198000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
59000 usd
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
109000 usd
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 usd
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets Contingency Resolution
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsContingencyResolution
1513000 usd
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets Contingency Resolution
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsContingencyResolution
0 usd
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations
14767000 usd
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations
71054000 usd
sdgr Noncash Or Part Noncash Acquisitions Of Lease Liabilities
NoncashOrPartNoncashAcquisitionsOfLeaseLiabilities
14767000 usd
sdgr Noncash Or Part Noncash Acquisitions Of Lease Liabilities
NoncashOrPartNoncashAcquisitionsOfLeaseLiabilities
71054000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations<div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade receivables.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not require customers to provide collateral to support accounts receivable. If deemed necessary, credit reviews of significant new customers may be performed prior to extending credit. The determination of a customer’s ability to pay requires judgment, and failure to collect from a customer can adversely affect revenue, cash flows, and results of operations.</span></div>
CY2022Q3 sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
12313000 usd
CY2021Q3 sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
5570000 usd
sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
36353000 usd
sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
17089000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
11057000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8271000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
22621000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
51816000 usd
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
17026000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
36403000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.67
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
21275000 usd
CY2022Q1 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-128000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1759000 usd
CY2022Q2 sdgr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Cash Contributions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCashContributions
600000 usd
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
504817000 usd
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
620927000 usd
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0 usd
CY2021 sdgr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Cash Contributions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCashContributions
2000000 usd
CY2021 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-113000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1887000 usd
CY2022Q2 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-294000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
2065000 usd
CY2022Q3 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-237000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1828000 usd
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 usd
CY2022Q3 sdgr Fair Value Assets No Transfers Between Level Amount
FairValueAssetsNoTransfersBetweenLevelAmount
0 usd
CY2021Q4 sdgr Fair Value Assets No Transfers Between Level Amount
FairValueAssetsNoTransfersBetweenLevelAmount
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P14Y
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3151000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2382000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
8441000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
5269000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
992000 usd
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1608000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2293000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
4112000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1016000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10720000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11447000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10995000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10568000 usd
CY2022Q3 sdgr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
104831000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
149577000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
53729000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
95848000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8683000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87165000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
199000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
137000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2166000 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0069
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71207992 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71207992 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70784184 shares
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9864000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7652000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29425000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19034000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.59
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y7M28D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0202
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-39853000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-39853000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-35007000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-35007000 usd
us-gaap Net Income Loss
NetIncomeLoss
-121979000 usd
us-gaap Net Income Loss
NetIncomeLoss
-121979000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69680000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69680000 usd
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70784184 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71140682 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71140682 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70481901 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70481901 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.99
us-gaap Gross Profit
GrossProfit
62318000 usd
us-gaap Gross Profit
GrossProfit
39259000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32885000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23219000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36980000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29850000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124112000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91761000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
17201000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
11115000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91830000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65759000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7161000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5556000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21260000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16175000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23318000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17014000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
67507000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46253000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11825000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1781000 usd
CY2022Q3 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
5273000 usd
CY2021Q3 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-627000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-16591000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
19279000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1231000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
286000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1263000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1063000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
199000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
137000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-39856000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-35011000 usd
us-gaap Profit Loss
ProfitLoss
-121981000 usd
us-gaap Profit Loss
ProfitLoss
-70504000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36980000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29850000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124112000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91761000 usd

Files In Submission

Name View Source Status
0001490978-22-000012-index-headers.html Edgar Link pending
0001490978-22-000012-index.html Edgar Link pending
0001490978-22-000012.txt Edgar Link pending
0001490978-22-000012-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdgr-20220930.htm Edgar Link pending
sdgr-20220930.xsd Edgar Link pending
sdgr-20220930x10qex101.htm Edgar Link pending
sdgr-20220930x10qex311.htm Edgar Link pending
sdgr-20220930x10qex312.htm Edgar Link pending
sdgr-20220930x10qex321.htm Edgar Link pending
sdgr-20220930x10qex322.htm Edgar Link pending
sdgr-20220930x10xqex104ind.htm Edgar Link pending
Show.js Edgar Link pending
sdgr-20220930_pre.xml Edgar Link unprocessable
sdgr-20220930_cal.xml Edgar Link unprocessable
sdgr-20220930_lab.xml Edgar Link unprocessable
sdgr-20220930_def.xml Edgar Link unprocessable
sdgr-20220930_htm.xml Edgar Link completed